Intravenous immunoglobulin for painful nerve damage
Treatments studied
Part of Brain & nervous system clinical trials.
This study tests whether giving an infusion of antibodies (called IVIG) can reduce pain in people with nerve damage that causes burning or stabbing pain. If you have painful small fiber neuropathy or sensory neuronopathy, this treatment might help calm your nerves and ease your pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a painful nerve problem called small fiber neuropathy or sensory neuronopathy.
- You are experiencing pain rated at least 5 out of 10 for at least 4 weeks.
- You have not had an allergic reaction to IVIG or other blood products in the past.
- You do not have severe heart conditions, kidney failure, or other serious medical issues listed in the study.
- You have not started or changed pain medication in the last 30 days.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether IVIG (an immune therapy made from donated antibodies) can reduce pain from autoimmune small fiber neuropathy. You may be a candidate if your tests show certain autoantibodies (TS-HDS, FGFR3, or Plexin-D1) and your symptom scores are high enough.
This study tests whether a special type of spinal cord stimulation (which uses mild electrical pulses to block pain) can help repair damaged small nerve fibers in people with small fiber neuropathy. If you have chronic nerve pain and meet the criteria, you may be able to join.
This study tests a multi-sensory (multiple-sense) stimulation approach to see if it can help people with nerve-related pain in the legs/feet. You must be able to safely take part in MRI-related sessions and answer questions about pain and health history.
This trial tests whether magnetic brain stimulation can reduce pain in people with small fiber neuropathy, a nerve condition that causes burning or shooting pain. If you have this condition, this treatment might offer a new way to ease your pain without major side effects.
This trial tests whether a combination of three immune-suppressing drugs (IVIg, cyclophosphamide, and methylprednisolone) given early can improve balance and sensation in people with a rare nerve condition caused by anti-Hu antibodies. The goal is to stop or slow the nerve damage before it gets worse.
This study tests a new gel (VMD-3866) applied to the skin to treat moderate nerve pain, numbness, or tingling caused by previous chemotherapy. It aims to see if the gel can safely reduce pain for people whose symptoms have been stable for at least 8 weeks.
Hear when a new Sensory Neuropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.